Literature DB >> 1461374

New insights into the cause of Parkinson's disease.

P Jenner1, A H Schapira, C D Marsden.   

Abstract

Current concepts as to the cause of Parkinson's disease (PD) suggest an inherited predisposition to environmental or endogenous toxic agents. Study of the substantia nigra after death in PD has highlighted three major changes: (1) evidence of oxidative stress and depletion of reduced glutathione; (2) high levels of total iron, with reduced ferritin buffering; and (3) mitochondrial complex I deficiency. Which of these is the primary event, generating a secondary cascade of changes culminating in nigral cell death, is unknown. In presymptomatic Lewy body-positive control brains, the nigra shows depletion of reduced glutathione content and, possibly, a reduction of complex I activity. Whatever the significance of these various abnormalities, be they causal or secondary, they provide novel targets for the development of new strategies to treat the cause of PD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461374     DOI: 10.1212/wnl.42.12.2241

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

Review 2.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

3.  Ginkgo biloba extracts EGb 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells.

Authors:  Elisabetta A Tendi; Francesca Bosetti; S Fenella Dasgupta; Anna Maria Giuffrida Stella; Katy Drieu; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

4.  The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease.

Authors:  Athan Baillet; Vanessa Chanteperdrix; Candice Trocmé; Pierre Casez; Catherine Garrel; Gérard Besson
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

5.  Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease.

Authors:  Shankar J Chinta; Jyothi M Kumar; Hongqiao Zhang; Henry Jay Forman; Julie K Andersen
Journal:  Free Radic Biol Med       Date:  2006-01-13       Impact factor: 7.376

6.  Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.

Authors:  F C Cheng; J S Kuo; L G Chia; G Dryhurst
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Fate of midbrain dopaminergic neurons controlled by the engrailed genes.

Authors:  H H Simon; H Saueressig; W Wurst; M D Goulding; D D O'Leary
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

8.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Authors:  Jordan J Elm
Journal:  Mov Disord       Date:  2012-10       Impact factor: 10.338

Review 10.  Oxygen toxicity induces apoptosis in neuronal cells.

Authors:  T Satoh; Y Enokido; T Kubo; M Yamada; H Hatanaka
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.